# CLEAR To Announce Second Quarter 2026 Financial Results On August 5, 2026
Canonical URL: https://biopharmsignal.com/news/YOU/clear-to-announce-second-quarter-2026-financial-results-on-august-5-2026-ad41d7b4
Ticker: YOU
Company: Clear Secure Inc
Source: Clear Secure Inc
Published: 2026-07-22 10:00 EST
Original Source URL: https://ir.clearme.com/news-events/press-releases/detail/193/clear-to-announce-second-quarter-2026-financial-results-on
## Summary

NEW YORK, July 22, 2026 /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU), the secure identity company, today announced that it will report…...

## Article Body
, /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU), the secure identity company, today announced that it will report financial results for the second quarter ending June 30, 2026 at approximately 6:00 a.m. ET on Wednesday, August 5, 2026. At 8:00 a.m. ET, results will be discussed via live webcast and teleconference.

Investors and analysts can access the live teleconference call by dialing toll-free 877-407-3089 for U.S. participants and +1 215-268-9854 for international participants. Listeners can access the live webcast HERE . A webcast replay will be available after the event on the investor relations website at https://ir.clearme.com .

About CLEAR The mission of CLEAR, the secure identity company, is to strengthen security and create frictionless experiences. With over 41 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you—making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we do not sell biometric or sensitive personal data. For more information, visit clearme.com.

Investor Contact ir@clearme.com

Media Contact media@clearme.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/clear-to-announce-second-quarter-2026-financial-results-on-august-5-2026-302831119.html

SOURCE CLEAR

Released July 22, 2026
## Recent Company News
- 2026-07-22 10:00 EST — [CLEAR To Announce Second Quarter 2026 Financial Results On August 5, 2026](https://biopharmsignal.com/news/YOU/clear-to-announce-second-quarter-2026-financial-results-on-august-5-2026-ad41d7b4) — Source: Clear Secure Inc
- 2026-06-29 20:15 EST — [Your Travel Day Super Hero Has Arrived: CLEAR Teams Up with Marvel Animation's "X-Men '97" Season 2 to Help Members Win the Day of Travel](https://biopharmsignal.com/news/YOU/your-travel-day-super-hero-has-arrived-clear-teams-up-with-marvel-animation-s-x--1b04f659) — Source: Clear Secure Inc
- 2026-06-29 10:00 EST — [CLEAR to Strengthen Caller Verification in Contact Centers with AWS](https://biopharmsignal.com/news/YOU/clear-to-strengthen-caller-verification-in-contact-centers-with-aws-a6b19977) — Source: Clear Secure Inc
- 2026-06-16 14:00 EST — [CLEAR Launches at Indianapolis International Airport](https://biopharmsignal.com/news/YOU/clear-launches-at-indianapolis-international-airport-e04b0732) — Source: Clear Secure Inc
- 2026-06-01 10:00 EST — [Concierge Powered by CLEAR Launched at MIA to Elevate Travel Experiences at Florida's Busiest Airport for International Passengers](https://biopharmsignal.com/news/YOU/concierge-powered-by-clear-launched-at-mia-to-elevate-travel-experiences-at-florida-s-busiest-airport-for-international-passengers) — Source: Clear Secure Inc
## Related News
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)
- 2026-07-22 12:30 EST — NRSN — [NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS](https://biopharmsignal.com/news/NRSN/neurosense-advances-primec-toward-new-drug-submission-to-health-canada-for-als-721c198c)
- 2026-07-22 12:30 EST — PRGO — [Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/PRGO/perrigo-to-release-second-quarter-2026-financial-results-on-august-5-2026-ff2ea2a5)
- 2026-07-22 12:08 EST — BIAF — [bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bio-7ee819d4)
- 2026-07-22 12:00 EST — MNPR — [Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease](https://biopharmsignal.com/news/MNPR/monopar-initiates-rolling-nda-submission-for-alxn1840-in-wilson-disease-e671ddcf)